1. Home
  2. SUPN vs PTRN Comparison

SUPN vs PTRN Comparison

Compare SUPN & PTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$45.61

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

PTRN

Pattern Group Inc.

HOLD

Current Price

$20.22

Market Cap

3.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUPN
PTRN
Founded
2005
2013
Country
United States
United States
Employees
N/A
2300
Industry
Biotechnology: Pharmaceutical Preparations
Catalog/Specialty Distribution
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.5B
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
SUPN
PTRN
Price
$45.61
$20.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
10
Target Price
$61.60
$19.56
AVG Volume (30 Days)
492.7K
1.4M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$392,755,000.00
N/A
Revenue This Year
$22.70
$27.89
Revenue Next Year
$19.14
$22.19
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$31.16
$9.19
52 Week High
$59.68
$20.82

Technical Indicators

Market Signals
Indicator
SUPN
PTRN
Relative Strength Index (RSI) 41.88 70.95
Support Level $43.67 $11.11
Resistance Level $46.89 N/A
Average True Range (ATR) 1.46 0.93
MACD -0.17 -0.01
Stochastic Oscillator 34.48 86.34

Price Performance

Historical Comparison
SUPN
PTRN

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

About PTRN Pattern Group Inc.

Pattern Group Inc is an e-commerce accelerator that uses its technology platform, data science, and a team of experts to drive growth for brands. The Company acquires inventory from brand partners to sell to consumers, enabling full control over content, pricing, logistics, and customer service. Brand partners that contract with the Company operate in various industries, including health and wellness, beauty and personal care, home and lifestyle, pet, sports and outdoors, and consumer electronics. The Company mainly derives its revenue in the United States by selling products to customers via online marketplaces. The company genrates majority of revenue from the US.

Share on Social Networks: